• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

皮肌炎中的恶性肿瘤:一项针对中国134例患者的单中心回顾性研究及潜在预测模型

Malignancy in dermatomyositis: a mono-centric retrospective study of 134 patients in China and a potential predictive model.

作者信息

Tang Zhuang-Li, Chi Chao-Cheng, Tang Zhen-Wei, Li Xia-Wei, Man Xiao-Yong

机构信息

Department of Dermatology, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.

Department of Gastrointestinal Surgery, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.

出版信息

Front Med (Lausanne). 2023 Jun 8;10:1200804. doi: 10.3389/fmed.2023.1200804. eCollection 2023.

DOI:10.3389/fmed.2023.1200804
PMID:37359002
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10285222/
Abstract

OBJECTIVES

To describe the demographics and phenotypes of malignancies-associated dermatomyositis (MADM) in east China and pinpoint potential factors indicative of malignancies in patients with dermatomyositis and establish a predictive model.

METHODS

We retrospectively analyzed clinical data from 134 patients with adult-onset dermatomyositis hospitalized between January 2019 and May 2022 in one comprehensive hospital. Clinical data including disease course, initial symptoms and signs, and demographic information were retrieved from the Electronic Medical Records System. Other parameters including myositis-specific autoantibodies profiles, ferritin, sedimentation, etc. were all referable. Multivariable multinomial logistic regression was employed to simulate a model to predict cancer risks. Receiver operating characteristic curve was adopted to evaluate the potency of the model.

RESULTS

134 patients with adult-onset dermatomyositis were aptly enrolled in this study based on inclusive and exclusive criteria: 12 (8.96%) with malignancies, 57 (42.53%) with aberrant tumor biomarkers but no malignancies, 65 (48.51%) with neither malignancies nor abnormal tumor biomarkers. Senior diagnostic age, higher LDH, higher ferritin, positive anti-TIF1γ and anti-Mi2 rather than anti-NXP2 autoantibodies were positive indicators of malignancies. Additionally, neither initial complaints nor signs were found to be correlated to a tendency towards malignancies. Digestive system, nasopharyngeal, and lung malignancies were mostly documented in east China. One multivariable multinomial logistic regression model was established to predict the phenotypes of dermatomyositis on the basis of potential malignancies and the overall sensitivity and specificity was satisfactory.

CONCLUSION

Positivity of anti-TIF1γ and anti-Mi2 autoantibodies are highly indicative of malignancies while the role of anti-NXP2 autoantibody in MADM in the Chinese population remains unclear. The phenotypes of malignancies can be predicted through the model and the predictive power is sufficient. More attention should be paid to malignancies screening in patients with aberrant tumor biomarkers but no malignancies, particularly digestive system, nasopharyngeal, and lung malignancies in patients with dermatomyositis but without malignancies.

摘要

目的

描述中国东部地区恶性肿瘤相关性皮肌炎(MADM)的人口统计学特征和表型,确定皮肌炎患者中提示恶性肿瘤的潜在因素,并建立预测模型。

方法

我们回顾性分析了2019年1月至2022年5月期间在一家综合医院住院的134例成人起病皮肌炎患者的临床资料。从电子病历系统中检索临床资料,包括病程、初始症状和体征以及人口统计学信息。其他参数,包括肌炎特异性自身抗体谱、铁蛋白、血沉等均可供参考。采用多变量多项逻辑回归来模拟预测癌症风险的模型。采用受试者工作特征曲线来评估模型的效能。

结果

根据纳入和排除标准,本研究恰当纳入了134例成人起病皮肌炎患者:12例(8.96%)患有恶性肿瘤,57例(42.53%)肿瘤生物标志物异常但无恶性肿瘤,65例(48.51%)既无恶性肿瘤也无肿瘤生物标志物异常。诊断年龄较大、乳酸脱氢酶较高、铁蛋白较高、抗TIF1γ和抗Mi2抗体阳性而非抗NXP2自身抗体阳性是恶性肿瘤的阳性指标。此外,未发现初始症状和体征与恶性肿瘤倾向相关。在中国东部地区,消化系统、鼻咽癌和肺癌恶性肿瘤最为常见。建立了一个多变量多项逻辑回归模型,以根据潜在恶性肿瘤预测皮肌炎的表型,总体敏感性和特异性令人满意。

结论

抗TIF1γ和抗Mi2自身抗体阳性高度提示恶性肿瘤,而抗NXP2自身抗体在中国人群MADM中的作用仍不清楚。通过该模型可以预测恶性肿瘤的表型,且预测能力足够。对于肿瘤生物标志物异常但无恶性肿瘤的患者,尤其是皮肌炎但无恶性肿瘤的患者,应更加关注消化系统、鼻咽癌和肺癌恶性肿瘤的筛查。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59f9/10285222/c4f468e80df2/fmed-10-1200804-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59f9/10285222/4cff6988b9e2/fmed-10-1200804-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59f9/10285222/54dc4e8e38dd/fmed-10-1200804-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59f9/10285222/c4f468e80df2/fmed-10-1200804-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59f9/10285222/4cff6988b9e2/fmed-10-1200804-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59f9/10285222/54dc4e8e38dd/fmed-10-1200804-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59f9/10285222/c4f468e80df2/fmed-10-1200804-g003.jpg

相似文献

1
Malignancy in dermatomyositis: a mono-centric retrospective study of 134 patients in China and a potential predictive model.皮肌炎中的恶性肿瘤:一项针对中国134例患者的单中心回顾性研究及潜在预测模型
Front Med (Lausanne). 2023 Jun 8;10:1200804. doi: 10.3389/fmed.2023.1200804. eCollection 2023.
2
Four dermatomyositis-specific autoantibodies-anti-TIF1γ, anti-NXP2, anti-SAE and anti-MDA5-in adult and juvenile patients with idiopathic inflammatory myopathies in a Hungarian cohort.四种特发性炎性肌病相关的自身抗体-抗 TIF1γ、抗 NXP2、抗 SAE 和抗 MDA5-在匈牙利特发性炎性肌病患者(成人和青少年)队列中。
Autoimmun Rev. 2014 Dec;13(12):1211-9. doi: 10.1016/j.autrev.2014.08.011. Epub 2014 Aug 23.
3
Myositis-specific autoantibodies and their association with malignancy in Italian patients with polymyositis and dermatomyositis.意大利多发性肌炎和皮肌炎患者的肌炎特异性自身抗体及其与恶性肿瘤的关联
Clin Rheumatol. 2017 Feb;36(2):469-475. doi: 10.1007/s10067-016-3453-0. Epub 2016 Oct 20.
4
Association of anti-NXP2 antibody with clinical characteristics and outcomes in adult dermatomyositis: results from clinical applications based on a myositis-specific antibody.抗 NXP2 抗体与成人皮肌炎临床特征和结局的关联:基于肌炎特异性抗体的临床应用结果。
Clin Rheumatol. 2021 Sep;40(9):3695-3702. doi: 10.1007/s10067-021-05667-x. Epub 2021 Mar 13.
5
[Retrospective analysis of anti-TIF1gamma, anti-NXP2 and anti-SAE1/2 antibodies carriers at Bordeaux university hospital from November 2014 to February 2017].[2014年11月至2017年2月在波尔多大学医院对抗TIF1γ、抗NXP2和抗SAE1/2抗体携带者的回顾性分析]
Rev Med Interne. 2019 Feb;40(2):70-81. doi: 10.1016/j.revmed.2018.11.003. Epub 2018 Dec 4.
6
Clinical and laboratory parameters predicting cancer in dermatomyositis patients with anti-TIF1γ antibodies.抗 TIF1γ 抗体阳性皮肌炎患者的临床和实验室参数预测癌症。
J Dermatol Sci. 2021 Dec;104(3):177-184. doi: 10.1016/j.jdermsci.2021.10.003. Epub 2021 Oct 13.
7
A retrospective cohort study in Chinese patients with adult polymyositis and dermatomyositis: risk of comorbidities and subclassification using machine learning.一项针对中国成人皮肌炎和多发性肌炎患者的回顾性队列研究:使用机器学习方法分析合并症的风险和亚分类。
Clin Exp Rheumatol. 2022 Feb;40(2):224-236. doi: 10.55563/clinexprheumatol/i2xeao. Epub 2021 Jun 26.
8
Calcinosis in juvenile dermatomyositis is influenced by both anti-NXP2 autoantibody status and age at disease onset.青少年皮肌炎中的钙质沉着受抗NXP2自身抗体状态和发病年龄的影响。
Rheumatology (Oxford). 2014 Dec;53(12):2204-8. doi: 10.1093/rheumatology/keu259. Epub 2014 Jul 1.
9
Anti-transcription intermediary factor 1 gamma (TIF1γ) antibody-positive dermatomyositis associated with ascending colon cancer: a case report and review of the literature.抗转录中介因子1γ(TIF1γ)抗体阳性皮肌炎合并升结肠癌:1例病例报告及文献复习
J Med Case Rep. 2021 Mar 22;15(1):142. doi: 10.1186/s13256-021-02664-1.
10
Clinical subsets of juvenile dermatomyositis classified by myositis-specific autoantibodies: Experience at a single center in Japan.特发性炎性肌病特异性自身抗体分类的青少年皮肌炎临床亚型:日本单中心经验。
Mod Rheumatol. 2019 Sep;29(5):802-807. doi: 10.1080/14397595.2018.1511025. Epub 2018 Sep 10.

引用本文的文献

1
Association Between Anti-TIF1-γ Antibody and Triple-Negative Breast Carcinoma in Dermatomyositis Patients: A Case Report.皮肌炎患者抗TIF1-γ抗体与三阴性乳腺癌之间的关联:一例报告
Clin Case Rep. 2025 Feb 10;13(2):e70157. doi: 10.1002/ccr3.70157. eCollection 2025 Feb.

本文引用的文献

1
The associations between myositis autoantibodies and clinical presentations in dermatomyositis.皮肌炎中肌炎自身抗体与临床表现之间的关联。
Australas J Dermatol. 2022 Nov;63(4):479-487. doi: 10.1111/ajd.13892. Epub 2022 Aug 2.
2
Autoantibodies and Cancer Association: the Case of Systemic Sclerosis and Dermatomyositis.自身抗体与癌症的关联:以系统性硬化症和皮肌炎为例。
Clin Rev Allergy Immunol. 2022 Dec;63(3):330-341. doi: 10.1007/s12016-022-08944-y. Epub 2022 May 20.
3
The Role of Myositis-Specific Autoantibodies in the Dermatomyositis Spectrum.
肌炎特异性自身抗体在皮肌炎谱系中的作用
Cureus. 2022 Mar 8;14(3):e22978. doi: 10.7759/cureus.22978. eCollection 2022 Mar.
4
Paraneoplastic Dermatomyositis.副肿瘤性皮肌炎
Am J Med. 2022 Aug;135(8):969-971. doi: 10.1016/j.amjmed.2022.01.016. Epub 2022 Feb 24.
5
Autoantibody Markers of Increased Risk of Malignancy in Patients with Dermatomyositis.皮肌炎患者恶性肿瘤风险增加的自身抗体标志物。
Clin Rev Allergy Immunol. 2022 Oct;63(2):289-296. doi: 10.1007/s12016-022-08922-4. Epub 2022 Feb 11.
6
A Study on Dermatomyositis and the Relation to Malignancy.皮肌炎及其与恶性肿瘤关系的研究
Curr Health Sci J. 2021 Jul-Sep;47(3):377-382. doi: 10.12865/CHSJ.47.03.07. Epub 2021 Sep 30.
7
Development and validation of a nomogram risk prediction model for malignancy in dermatomyositis patients: a retrospective study.皮肌炎患者恶性肿瘤诺模图风险预测模型的开发与验证:一项回顾性研究
PeerJ. 2021 Dec 9;9:e12626. doi: 10.7717/peerj.12626. eCollection 2021.
8
Clinical and laboratory parameters predicting cancer in dermatomyositis patients with anti-TIF1γ antibodies.抗 TIF1γ 抗体阳性皮肌炎患者的临床和实验室参数预测癌症。
J Dermatol Sci. 2021 Dec;104(3):177-184. doi: 10.1016/j.jdermsci.2021.10.003. Epub 2021 Oct 13.
9
Characteristics of dermatomyositis patients with and without associated malignancy.特发性炎症性肌病患者伴发和不伴发恶性肿瘤的特征。
J Dtsch Dermatol Ges. 2021 Nov;19(11):1601-1611. doi: 10.1111/ddg.14566. Epub 2021 Nov 5.
10
Dermatomyositis and malignancy: should all patients with dermatomyositis undergo malignancy screening?皮肌炎与恶性肿瘤:所有皮肌炎患者都应接受恶性肿瘤筛查吗?
Ann Transl Med. 2021 Mar;9(5):432. doi: 10.21037/atm-20-5215.